Company: PHR
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001412408-25-000039
Chunk: 126

Company: Phreesia, Inc.
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 8
Chunk 126
---
 capitalized internal-use software was $3,022 and $2,279, respectively.(d) Intangible assets and goodwill

16

Table of Contents

The following presents the details of intangible assets as of April 30, 2025 and January 31, 2025:Useful Life (years)April 30, 2025January 31, 2025Acquired technology5 to 7$9,310 $9,310 Customer relationship7 to 1517,940 17,940 License156,200 6,200 Trademarks153,100 3,100 Total intangible assets, gross carrying value$36,550 $36,550 Less: accumulated amortization(9,277)(8,407)Net carrying value$27,273 $28,143 The weighted average remaining useful life for acquired technology in years was 4.9 and 5.1 as of April 30, 2025 and January 31, 2025, respectively. The remaining useful life for customer relationships in years was 11.4 and 11.6 as of April 30, 2025 and January 31, 2025, respectively. The remaining useful life for the license to the Patient Activation Measure ("PAM"®) in years was 11.6 and 11.8 as of April 30, 2025 and January 31, 2025, respectively. The remaining useful life for the trademarks in years was 13.3 and 13.5 as of April 30, 2025 and January 31, 2025, respectively.Amortization expense associated with intangible assets for both the three months ended April 30, 2025 and 2024, was $870.The estimated amortization expense for intangible assets for the next five years and thereafter was as follows as of April 30, 2025:April 30, 20252026 (Remaining nine months)$2,581 Fiscal Years Ending January 31,20273,157 20283,157 20293,057 2030 - thereafter15,321 Total$27,273 There were no changes to the Company's goodwill balance during the three months ended April 30, 2025. The Company did not record any impairments of goodwill during the three months ended April 30, 2025 or 2024. (e) Accounts receivable